Home » Stocks » CNTA

Centessa Pharmaceuticals Limited (CNTA)

Centessa Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -10.66M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Centessa Pharmaceuticals Limited has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About CNTA

Centessa Pharmaceuticals was conceived by combining the primary strengths of the asset-centric model with the benefits of diversification and scale typically attributed to traditional large R&D organizations. The asset-centric model refers to single-purpose companies which are focused on developing a single program or programs associated with a single biological pathway. We have implemented this reimagined approach to R&D by initially combining a curated portfolio of ten wholly-owned asset-centric companies, which we refer to as the Centessa Su... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Saurabh Saha, M.D., Ph.D.
Employees
34
Stock Exchange
NASDAQ
Ticker Symbol
CNTA
Full Company Profile

Financial Performance

Financial Statements